Product overview

Name Benidipine hydrochloride
Alternative names KW 3049
Purity >99%
Description Ca2+ channel inhibitor
Write Your Own Review
You're reviewing:Benidipine hydrochloride
Rate this item:

Biological Data

Biological description L-, N- and T-type Ca2+ channel inhibitor (IC50 = 2.7 nM for ICa inhibition). Inhibits the activation of aldosterone-induced mineralocorticoid receptor. Shows anti-atherosclerotic, antihypertensive and cardioprotective actions.

Solubility & Handling

Storage instructions room temperature (desiccate)
Solubility overview Soluble in DMSO (75mM) or ethanol (10mM)
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Purity >99%
Chemical name (4R)-rel-1,4-Dihydro-2,6-dimethyl-4 -(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 3-methyl 5-[(3R)-1-(phenylmethyl)-3-piperidinyl] ester hydrochloride
Molecular Weight 542.02
Chemical structure Benidipine hydrochloride  [91599-74-5] Chemical Structure
Molecular Formula C28H31N3O6.HCl
CAS Number 91599-74-5
PubChem identifier 76968919
SMILES CC1=C(C(OC)=O)[C@@H]([C@]2=CC([N+]([O-])=O)=CC=C2)C(C(O[C@H]3CN(CC4=CC=CC=C4)CCC3)=O)=C(C)N1.CC5=C(C(OC)=O)[C@H]([C@]6=CC([N+]([O-])=O)=CC=C6)C(C(O[C@@H]7CN(CC8=CC=CC=C8)CCC7)=O)=C(C)N5.Cl.Cl
InChiKey SPMJXDRNJQIBTB-IMEZZWDRSA-N

References for Benidipine hydrochloride

References are publications that support the biological activity of the product
  • The L-, N-, and T-type triple calcium channel blocker benidipine acts as an antagonist of mineralocorticoid receptor, a member of nuclear receptor family.

    Kosaka H et al (2010) Eur J Pharmacol 635(1-3) : 49-55.
  • Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker.

    Yao K et al (2006) J Pharmacol Sci 100(4) : 243-61.
  • Mechanisms of long-lasting effects of benidipine on Ca current in guinea-pig ventricular cells.

    Yamamoto M et al (1990) Br J Pharmacol 100(4) : 669-76.

3 Item(s)